EP 1171153 A2 20020116 - NOVEL MEDICAL USE OF ALPHA-1-ACIDIC GLYCOPROTEIN (AAG) OR OROSOMUCOID
Title (en)
NOVEL MEDICAL USE OF ALPHA-1-ACIDIC GLYCOPROTEIN (AAG) OR OROSOMUCOID
Title (de)
NEUE MEDIZINISCHE VERWENDUNG VON ALPHA-1-SAUREM GLYKOPROTEIN (AAG ODER OROSOMUCOID)
Title (fr)
NOUVELLE UTILISATION MEDICALE DE GLYCOPROTEINE ALPHA-1-ACIDE (AAG) OU D'OROSOMUCOIDE
Publication
Application
Priority
- AT 0000090 W 20000414
- AT 66799 A 19990414
Abstract (en)
[origin: WO0061170A2] The invention relates to the use of alpha 1-acidic glycoprotein (AAG) for producing medicaments for influencing or accelerating detoxification. The invention also relates to a kit containing alpha 1-acidic glycoprotein and to a plasmapheresis kit for an additional plasma exchange with plasma and/or serum albumin solution.
IPC 1-7
IPC 8 full level
A61K 9/08 (2006.01); A61K 9/14 (2006.01); A61K 35/16 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 47/12 (2006.01); A61P 25/36 (2006.01); A61P 39/02 (2006.01); C07K 14/47 (2006.01)
CPC (source: EP US)
A61K 38/1709 (2013.01 - EP US); A61P 25/36 (2018.01 - EP); A61P 39/02 (2018.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0061170 A2 20001019; WO 0061170 A3 20010510; AT 407485 B 20010326; AT A66799 A 20000815; AU 3945300 A 20001114; CA 2369472 A1 20001019; EP 1171153 A2 20020116; JP 2002541209 A 20021203; US 2002147137 A1 20021010
DOCDB simple family (application)
AT 0000090 W 20000414; AT 66799 A 19990414; AU 3945300 A 20000414; CA 2369472 A 20000414; EP 00918560 A 20000414; JP 2000610502 A 20000414; US 97831701 A 20011015